U.S. Pharma Stock News

In April 2026, Enterprise Financial Services Corp reported first-quarter 2026 results with net income of US$49.4 million and diluted EPS of US$1.30, supported by higher net interest income, solid credit metrics, and a tax-equivalent net interest margin of 4.28%. The company also completed a multi-year repurchase of 1,368,517 shares and approved higher common and ongoing preferred dividends, underscoring an increased emphasis on returning capital to shareholders while maintaining a...

Perrigo (PRGO) opened Q1 2026 with revenue of US$969.2 million and a basic EPS loss of US$2.81, while net income excluding extra items came in at a loss of US$389.9 million. Over the past six reported quarters, revenue has ranged between US$969.2 million and US$1.14 billion and basic EPS has moved from a small profit of US$0.09 in Q3 2025 to a loss of US$10.20 in Q4 2025 and US$2.81 in the latest quarter, giving investors a wide view of how the income statement has changed across different...

Investors were disappointed with Waystar Holding Corp.'s ( NASDAQ:WAY ) earnings, despite the strong profit numbers...

Shareholders will be ecstatic, with their stake up 21% over the past week following Axsome Therapeutics, Inc. 's...

Last week, Via Transportation, Inc.'s (NYSE:VIA) stock jumped 12%, but insiders who sold US$29m worth of stock in over...

T-Mobile US, Inc. ( NASDAQ:TMUS ) shareholders (or potential shareholders) will be happy to see that the Chief...

It's been a good week for ADC Therapeutics SA ( NYSE:ADCT ) shareholders, because the company has just released its...

Boise Cascade Company ( NYSE:BCC ) defied analyst predictions to release its quarterly results, which were ahead of...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Last week saw the newest quarterly earnings release from Hess Midstream LP ( NYSE:HESM ), an important milestone in the...

CoStar Group, Inc. ( NASDAQ:CSGP ) shareholders (or potential shareholders) will be happy to see that the President...

Last week's profit announcement from MediaAlpha, Inc. ( NYSE:MAX ) was underwhelming for investors, despite headline...

As you might know, Labcorp Holdings Inc. ( NYSE:LH ) recently reported its first-quarter numbers. The result was...

The Cheesecake Factory Incorporated ( NASDAQ:CAKE ) shareholders are probably feeling a little disappointed, since its...

We'd be surprised if Bank of Hawaii Corporation ( NYSE:BOH ) shareholders haven't noticed that the Independent...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Key context for Synopsys after recent performance shift Synopsys (SNPS) has drawn fresh attention after a strong recent price move, with the stock up about 27% over the past month and roughly 23% in the past 3 months. That performance sits against an already positive backdrop, with total returns of about 5% over the past year, 36% across 3 years, and 121% over 5 years, prompting closer scrutiny of what investors are currently paying for the stock. See our latest analysis for Synopsys. The...

The Toro Company recently reported past first-quarter fiscal 2026 results that exceeded analyst expectations and raised its full-year guidance, powered by strong professional segment performance and contributions from its Tornado Infrastructure Equipment acquisition. The company also underscored continued investment in innovation and operational excellence, suggesting its professional equipment and infrastructure offerings are becoming increasingly important within its overall business...

What recent performance suggests for BellRing Brands (BRBR) BellRing Brands (BRBR) has seen its stock retreat recently, with a last close of $11.10 and negative returns over the past week, month, past 3 months, year to date, and past year. At the same time, the company reports annual revenue of $2.33b and net income of $158.2m. This reflects its position as a US-focused provider of ready to drink protein shakes, powders, and nutrition bars. See our latest analysis for BellRing...

Henry Schein (HSIC) is back in focus after reporting Q1 2026 results that topped analyst estimates, reaffirming 2026 guidance, and highlighting progress on value creation plans and ongoing share repurchases. See our latest analysis for Henry Schein. Despite better than expected Q1 results, reaffirmed 2026 guidance, and continued buybacks, Henry Schein’s short term share price performance has been weak, with a 30 day share price return of a 3.23% decline, while the 1 year total shareholder...

DENTSPLY SIRONA (XRAY) has opened 2026 with Q1 revenue of US$880 million and a basic EPS loss of US$0.05, alongside net income excluding extra items of a US$10 million loss, setting a cautious tone around current profitability. Over the past year, the company has seen quarterly revenue move between US$879 million and US$961 million, while basic EPS has ranged from a profit of US$0.10 to a loss of US$2.16. This underlines how volatile earnings have been even as the top line has stayed close to...

Eaton (NYSE:ETN) is back in focus after reporting record first quarter 2026 results, beating analyst expectations on sales and earnings while pairing that with more cautious guidance that prompted a pullback in the stock. See our latest analysis for Eaton. At a share price of $421.39, Eaton has seen strong short term momentum with a 15.8% 30 day share price return and a 28.74% year to date share price return, alongside a 40.66% 1 year total shareholder return, as investors weigh record...

Ingevity (NGVT) has drawn fresh attention after reporting first quarter 2026 results, with sales of US$258 million and net income of US$59.8 million, compared to US$247.9 million and US$20.5 million a year earlier. See our latest analysis for Ingevity. The earnings release appears to have been a key catalyst for the recent share price move, with a 10.49% 1 month share price return and a 29.59% year to date share price return. The 1 year total shareholder return of 98.5% points to strong...

Wondering whether Blue Owl Capital is attractively priced today, or if the recent excitement has already been baked into the stock. The share price closed at US$10.54, with recent returns of 18.7% over 7 days and 24.7% over 30 days, set against a year to date return of negative 31.2% and a 1 year return of negative 38.3%. These swings sit against a backdrop of ongoing interest in alternative asset managers and the broader capital markets sector. In this environment, investors often reassess...